Mankind Pharma is an Indian
pharmaceutical and healthcare products company, headquartered in
Delhi. The company has products in therapeutic areas ranging from
antibiotics, to
gastrointestinal,
cardiovascular,
dermal, and
erectile dysfunction
Erectile dysfunction (ED), also called impotence, is the type of sexual dysfunction in which the penis fails to become or stay erect during sexual activity. It is the most common sexual problem in men.Cunningham GR, Rosen RC. Overview of male ...
medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India.
The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales.
Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in
condom
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use—and use at every act of in ...
s, Prega News in
pregnancy test kits, and Unwanted-72 in
emergency contraception.
History
Mankind Pharma was incorporated in 1991, and actively started its operations in 1995, with the contributions of two brothers,
Ramesh C. Juneja and Rajeev Juneja, who established the company with a seed capital of . The company was started with 20 employees and launched in two states in the first year of its operation.
Mankind Pharma initially targeted price-sensitive drugs, with a focus on rural market; its early products included antibacterial drug Zenflox and prescription antibiotic Moxikind CV, which were priced at a steep discount to the existing products in the market. The company ventured into the
over-the-counter segment in 2007, focusing primarily on sexual healthcare products.
The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in 2007. It acquired Longifene-an appetite stimulant for children in January 2010 which was earlier a brand of
UCB.
In 2017, Mankind Pharma established
Pathkind Labs
Pathkind Labs is an Indian service provider of diagnostic and related healthcare tests. It was founded in 2016. The business has 70 diagnostic labs and over 2000 centers in India and is accredited with the NABL and NABH.
History
Pathkind La ...
, a provider of diagnostics and healthcare tests.
In 2019, Mankind became the first Indian company and second only in the world to develop and launch
Dydrogesterone, a drug used in high-risk pregnancies and infertility by the brand name Dydroboon.
In 2022, Mankind acquired
Panacea Biotec Pharma's domestic formulations brands in India and Nepal for . It then acquired a respiratory treatment product, and an infant skincare brand from
Dr. Reddy's Laboratories. It also bought a majority stake in the
Ayurvedic
Ayurveda () is an alternative medicine system with historical roots in the Indian subcontinent. The theory and practice of Ayurveda is pseudoscientific. Ayurveda is heavily practiced in India and Nepal, where around 80% of the population rep ...
and herbal products manufacturer, Upakarma Ayurveda.
In 2022, the company entered
agritech and
pet care segments.
In April 2023, Mankind Pharma launched its
initial public offering (IPO), with existing investors selling approx. worth of shares.
See also
*
Pharmaceutical industry in India
References
External links
*
Mankind Pharmaat
IBM
{{Authority control
Generic drug manufacturers
Manufacturing companies based in Delhi
Pharmaceutical companies of India
Pharmaceutical companies established in 1991
Indian brands
Indian companies established in 1991
Companies listed on the National Stock Exchange of India
Companies listed on the Bombay Stock Exchange
2023 initial public offerings